Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.82

+2.0%

11:42 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3227)	3/29/2001 12:01:03 AM
From: Jibacoa	Read Replies (1) of 52153

DYAX: Had a nice move today.They announced yesterday that they had signed Zyomyx as a new licensee. That apparently was #51, since last month they displayed a list of 50 licensees that was quite impressive.<g> yahoo.marketguide.com The insiders hold 79% and institutions 36%(171% of the float)There are 18.8 million shares out, but the float is only 4 million and the short ratio is around 18% with about 5 or 6 days to cover based on the average daily volume.<g> The volume increased nicely today when the price went over the average lines. In November before the down trend started, the stock was trading around 46.<g> It seems that it still has some room to go.<g> siliconinvestor.com siliconinvestor.com Caveat: I bought some today at 7 1/4.(I plan to hold it as long as the price stays above 7 and above the average lines on the 30 minutes chart)I don't expect for it to go above 14(based on the daily chart, but that would be fine with me) <g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next